EPISODE · Apr 27, 2026 · 16 MIN
Episode 22 – Myasthenia gravis treatment landscape: What to expect in the future
from Unlocking Myasthenia gravis · host medthority
Episode 22 – Maria Da Silva Leite and Nils Erik Gilhus examine how MG treatment approaches are evolving, with a focus on antibody-defined subtypes, treatment goals, and long-term disease control. They highlight how improved disease characterization is increasingly shaping therapeutic decision-making and consider the balance between efficacy and treatment burden, as well as how emerging targeted therapies and biomarkers may enable more selective, patient-centered management in the future.
What this episode covers
Episode 22 – Maria Da Silva Leite and Nils Erik Gilhus examine how MG treatment approaches are evolving, with a focus on antibody-defined subtypes, treatment goals, and long-term disease control. They highlight how improved disease characterization is increasingly shaping therapeutic decision-making and consider the balance between efficacy and treatment burden, as well as how emerging targeted therapies and biomarkers may enable more selective, patient-centered management in the future.
NOW PLAYING
Episode 22 – Myasthenia gravis treatment landscape: What to expect in the future
No transcript for this episode yet
Similar Episodes
Jun 22, 2026 ·2m
Jun 22, 2026 ·2m
Jun 21, 2026 ·2m
Jun 21, 2026 ·2m
Jun 19, 2026 ·2m